3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
13
Phase 1/2
4
Phase 1
4
Phase 3
3
Phase NA
2
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Lymphoid
2
Conditions
Sarcoma
3
Vomiting
2
Neoplasms
2
Nausea
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia
2
Hodgkin Disease
2
Thalassemia
1
Teratoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Medulloblastoma
1
Lymphoma, Follicular
1
Hepatoblastoma
1
Hematologic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
21
fludarabine phosphate
13
Cyclosporine
11
Antilymphocyte Serum
11
Peripheral Blood Stem Cell Transplantation
10
Methotrexate
10
Busulfan
10
Cytarabine
9
Filgrastim
8
Radiotherapy
7
Dexamethasone
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Methylprednisolone
6
Melphalan
6
Exercise
6
fludarabine
5
Vincristine
5
Daunorubicin
5
Cord Blood Stem Cell Transplantation
5
pegaspargase
4
Rituximab
4
Palliative Care
4
Mercaptopurine
4
Etoposide
4
Early Intervention, Educational
4
Blood Specimen Collection
4
Asparaginase
4
Alemtuzumab
4
Thioguanine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia
×
Mesna
×
Clear all
NCT00578461
2016-04-22
REGKINE
Baylor College of Medicine
Phase NA
Terminated
26 enrolled
7 charts
NCT00578539
2016-04-22
REGALE
Baylor College of Medicine
Phase NA
Terminated
24 enrolled
7 charts